Pratley, R E <br/><br/>
Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).  [electronic resource] 

 -  Diabetes, obesity & metabolism  Mar 2013 
 - 234-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--blood<br/>Dizziness--chemically induced<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Metformin--administration & dosage<br/>Middle Aged<br/>Nausea--chemically induced<br/>Peptides--administration & dosage<br/>Pioglitazone<br/>Sulfonylurea Compounds--administration & dosage<br/>Thiazolidinediones--administration & dosage<br/>Treatment Outcome